JAMA at CCR, Insulin Cost Caps for Medicare Beneficiaries, Mazdutide in Obesity and Orforglipron in Diabetes, and more

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, Linda Brubaker, MD, Deputy Editor, and Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for articles published from June 6-12, 2026. Related Content:

• Audio Highlights